The disease used to be uniformly fatal, with a 5-year survival rate between 10 and 35%. As a result, treatment was radical surgery. New multidrug chemotherapy regimens with or without radiation therapy are now used in combination with less radical surgery with good results, although outcome data are not yet available.
Sarcoma botryoides
Lymphangioma circumscriptum
Dermatofibrosarcoma protuberans
Steatocystoma multiplex
Dermatofibroma
Generalized trichoepithelioma
Pyogenic granuloma
Merkel-cell carcinoma